Microbial cells, methods of producing the same, and uses thereof
The present invention relates to microbial cells, including but not limited to aerobic bacteria cells and anaerobic bacteria cells, as well as yeast cells, and methods for producing the cells, feed additives and compositions comprising the cells, and uses involving administration of the cells to animals.
1. A method of producing freeze-dried Megasphaera elsdenii cells on a commercial scale, comprising:
(a) preparing a liquid culture under anaerobic conditions comprising M. elsdenii cells and a growth media comprising at least two carbon sources selected from the group consisting of: casein, lactate, dextrose, fructose, fructan, glucose, sucrose, lactose, maltose, acetate, glycerol, mannitol, saccharose, xylose, molasses, fucose, glucosamine, dextran, a fat, an oil, glycerol, sodium acetate, arabinose, soy protein, soluble protein, raffinose, amylose, starch, and combinations thereof,
(b) harvesting the cells,
(c) adding at least one cryoprotectant to the harvested cells,
(d) freezing the cells,
(e) freeze-drying the cells, and
(f) obtaining about 1×10 7 to about 1×10 12 CFU/g of viable M. elsdenii cells after freeze-drying, wherein the method is performed under anaerobic conditions on a commercial scale, and wherein the cryoprotectant is fructose, glucose, sucrose, trehalose, maltodextrin, betaine, or combinations thereof.
2. A method of producing freeze-dried Megasphaera elsdenii cells on a commercial scale, comprising:
(a) preparing a liquid culture comprising M. elsdenii cells and a growth media,
(b) harvesting the cells within 12 hours after the culture has ended its exponential growth phase and before the culture has begun its stationary growth phase,
(c) adding at least one cryoprotectant to the harvested cells,
(d) freezing the cells at a temperature of about −80° C. to about −210° C. within about 5 hours of harvesting,
(e) freeze-drying the cells, and
(f) obtaining about 1×10 7 to about 1×10 12 CFU/g of viable M. elsdenii cells after freeze-drying, wherein the method is performed under anaerobic conditions on a commercial scale, and wherein the cryoprotectant is fructose, glucose, sucrose, trehalose, maltodextrin, betaine, or combinations thereof.
3. A method of producing freeze-dried Megasphaera elsdenii cells on a commercial scale, comprising:
(a) preparing a liquid culture comprising M. elsdenii cells and a growth media,
(b) harvesting the cells within 12 hours after the culture has ended its exponential growth phase and before the culture has begun its stationary growth phase,
(c) adding at least one cryoprotectant to the harvested cells,
(d) freezing the cells at a temperature of about −80° C. to about −210° C. within about 5 hours of harvesting,
(e) freeze-drying the cells, and
(f) obtaining about 1×10 7 to about 1×10 12 CFU/g of viable M. elsdenii cells after freeze-drying, wherein the method is performed under anaerobic conditions on a commercial scale, and wherein the cryoprotectant is fructose, glucose, sucrose, trehalose, maltodextrin, betaine, or combinations thereof.
4. The method of claim 1 , wherein the pH of the M. elsdenii culture prior to harvesting is between about 4.5 to about 7.0.
5. A method of producing freeze-dried anaerobic bacterial cells on a commercial scale, comprising:
(a) preparing a liquid culture under anaerobic conditions or partial anaerobic conditions comprising anaerobic bacterial cells and a growth media comprising at least two carbon sources selected from the group consisting of: peptone, casein, lactate, dextrose, fructose, fructan, glucose, sucrose, lactose, maltose, acetate, glycerol, mannitol, sorbitol, saccharose, xylose, molasses, fucose, glucosamine, dextran, a fat, an oil, glycerol, sodium acetate, arabinose, soy protein, soluble protein, raffinose, amylose, starch, tryptone, yeast extract, and combinations thereof,
(b) harvesting the cells,
(c) adding at least one cryoprotectant to the harvested cells,
(d) freezing the cells at a temperature of about −80° C. to about −210° C. within about 5 hours of harvesting,
(e) freeze-drying the cells, and
(f) obtaining about 1×10 7 to about 1×10 12 CFU/g of viable anaerobic bacterial cells after freeze-drying, wherein the method is performed under anaerobic conditions on a commercial scale, and wherein the cryoprotectant is fructose, glucose, sucrose, trehalose, maltodextrin, betaine, or combinations thereof.
6. The method of claim 5 , wherein the pH of the anaerobic bacterial culture prior to harvesting is between about 4.0 to about 9.0.
7. The method of claim 1 , wherein the cryoprotectant is sucrose.
8. The method of claim 2 , wherein the cryoprotectant is sucrose.
9. The method of claim 3 , wherein the cryoprotectant is sucrose.
10. The method of claim 1 , wherein the about 1×10 7 to about 1×10 12 CFU/g of the freeze-dried M. elsdenii cells are viable after storage at a temperature of about 25° C. for at least 2 weeks.
11. The method of claim 2 , wherein the about 1×10 7 to about 1×10 12 CFU/g of the freeze-dried M. elsdenii cells are viable after storage at a temperature of about 25° C. for at least 2 weeks.
12. The method of claim 3 , wherein the about 1×10 7 to about 1×10 12 CFU/g of the freeze-dried M. elsdenii cells are viable after storage at a temperature of about 25° C. for at least 2 weeks.
13. The method of claim 5 , wherein the about 1×10 7 to about 1×10 12 CFU/g of the freeze-dried M. elsdenii cells are viable after storage at a temperature of about 25° C. for at least 2 weeks.
14. The method of claim 1 , wherein the about 1×10 7 to about 1×10 12 CFU/g of the freeze-dried M. elsdenii cells are viable after storage at a temperature of about 4° C. for at least 1 month.
15. The method of claim 2 , wherein the about 1×10 7 to about 1×10 12 CFU/g of the freeze-dried M. elsdenii cells are viable after storage at a temperature of about 4° C. for at least 1 month.
16. The method of claim 3 , wherein the about 1×10 7 to about 1×10 12 CFU/g of the freeze-dried M. elsdenii cells are viable after storage at a temperature of about 4° C. for at least 1 month.
17. The method of claim 5 , wherein the about 1×10 7 to about 1×10 12 CFU/g of the freeze-dried M. elsdenii cells are viable after storage at a temperature of about 4° C. for at least 1 month.
18. The method of claim 5 , wherein the cryoprotectant is sucrose.
19. The method of claim 1 , wherein the method further comprises encapsulating the freeze-dried Megasphaera elsdenii cells.
20. The method of claim 2 , wherein the method further comprises encapsulating the freeze-dried Megasphaera elsdenii cells.
21. The method of claim 3 , wherein the method further comprises encapsulating the freeze-dried Megasphaera elsdenii cells.
22. The method of claim 5 , wherein the method further comprises encapsulating the freeze-dried anaerobic bacterial cells.
23. A method of producing freeze-dried M. elsdenii cells on a commercial scale, comprising:
(a) preparing a liquid culture under anaerobic conditions comprising M. elsdenii cells and a growth media comprising one or more carbon sources selected from the group consisting of: casein, lactate, dextrose, fructose, fructan, glucose, sucrose, lactose, maltose, acetate, glycerol, mannitol, saccharose, xylose, molasses, fucose, glucosamine, dextran, a fat, an oil, glycerol, sodium acetate, arabinose, soy protein, soluble protein, raffinose, amylose, starch, and combinations thereof,
(b) harvesting the cells within 12 hours after the culture has ended its exponential growth phase and before the culture has begun its stationary growth phase,
(c) adding a cryoprotectant to the harvested cells, wherein the cryoprotectant is selected from one or more of sucrose, lactose, milk powder, infant formula, or skim milk, and wherein the cryoprotectant is present at about 1% to about 20% (w/v) of the culture,
(d) freezing the cells at a temperature of about −20° C. to about −196° C. within about 5 hours of harvesting,
(e) freeze-drying the cells, and
(f) obtaining about 1×10 7 to about 1×10 12 CFU/g of viable M. elsdenii cells after storage at a temperature of about 25° C. for at least 2 weeks, wherein the method is performed under anaerobic conditions on a commercial scale.
24. The method of claim 1 , wherein the cryoprotectant is in a solution, wherein the cryoprotectant solution is added to the harvested cells at a ratio of 1/10 to 1/5.
25. The method of claim 2 , wherein the cryoprotectant is in a solution, wherein the cryoprotectant solution is added to the harvested cells at a ratio of 1/10 to 1/5.
26. The method of claim 3 , wherein the cryoprotectant is in a solution, wherein the cryoprotectant solution is added to the harvested cells at a ratio of 1/10 to 1/5.
27. The method of claim 5 , wherein the cryoprotectant is in a solution, wherein the cryoprotectant solution is added to the harvested cells at a ratio of 1/10 to 1/5.